These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8253329)

  • 1. [Chronic active cirrhogenic hepatitis induced by fenofibrate].
    Chatrenet P; Regimbeau C; Ramain JP; Penot J; Bruandet P
    Gastroenterol Clin Biol; 1993; 17(8-9):612-3. PubMed ID: 8253329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic lesion of the interlobular bile ducts induced by fenofibrate].
    Lepicard A; Mallat A; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1994; 18(11):1033-5. PubMed ID: 7705563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible nitrofurantoin-induced chronic active hepatitis and hepatic cirrhosis in a patient awaiting liver transplantation.
    Burgert SJ; Burke JP; Box TD
    Transplantation; 1995 Feb; 59(3):448-9. PubMed ID: 7871583
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
    Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases].
    Ben Yahia M; Mavier P; Métreau JM; Zafrani ES; Fabre M; Gatineau-Saillant G; Dhumeaux D; Mallat A
    Gastroenterol Clin Biol; 1993; 17(12):959-62. PubMed ID: 8125230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecomastia associated with fenofibrate.
    Gardette V; Vezzosi D; Maiza JC; Montastruc JL; Olivier P
    Ann Pharmacother; 2007 Mar; 41(3):508-10. PubMed ID: 17341535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic cirrhogenic hepatitis induced by germander].
    Dao T; Peytier A; Galateau F; Valla A
    Gastroenterol Clin Biol; 1993; 17(8-9):609-10. PubMed ID: 8253327
    [No Abstract]   [Full Text] [Related]  

  • 9. Fenofibrate-induced myopathy.
    Ghosh B; Sengupta S; Bhattacharjee B; Majumder A; Sarkar SB
    Neurol India; 2004 Jun; 52(2):268-9. PubMed ID: 15269493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actualities in the histopathological interpretation of chronic hepatitis. A review of the main classifications.
    Stăniceanu F; Ardeleanu C; Zurac S; Hălălău F; Nicolescu P
    Rom J Morphol Embryol; 1998; 44(1-4):35-44. PubMed ID: 15678841
    [No Abstract]   [Full Text] [Related]  

  • 11. [Celiac disease in adults associated with active chronic cirrhogenic hepatitis].
    Weiffenbach E; Eugène C; Anciaux ML; Bergue A; Quevauvilliers J
    Presse Med; 1987 Oct; 16(32):1596-7. PubMed ID: 2958836
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural history of hepatectomy regarding liver function: a study of both normal livers and livers with chronic hepatitis and cirrhosis.
    Ezaki T; Koyanagi N; Toyomasu T; Ikeda Y; Sugimachi K
    Hepatogastroenterology; 1998; 45(23):1795-801. PubMed ID: 9840150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a long pre-operative hospital stay before hepatectomy improve liver dysfunction in HCC patients with chronic liver disease?
    Ezaki T; Koyanagi N; Toyomasu T; Ikeda Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):472-6. PubMed ID: 9164521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrofurantoin-induced chronic active hepatitis.
    Amit G; Cohen P; Ackerman Z
    Isr Med Assoc J; 2002 Mar; 4(3):184-6. PubMed ID: 11908259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of sIL-2R detection in various hepatic diseases].
    Xuan SY; Jiang LM; Lu WH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Apr; 18(2):92-4. PubMed ID: 9812507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tumor markers in chronic liver disease.
    Kadayifci A; Simsek H; Savas MC; Toppare M
    Neoplasma; 1996; 43(1):17-21. PubMed ID: 8843954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of serum free insulin-like growth factor 1 in patients with chronic viral hepatitis].
    Lou M; Song N; Jin X; Luo SQ; Wang JJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):291-2. PubMed ID: 11986710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histological aspects of chronic HCV infection and cirrhosis.
    Giusti G; Pasquale G; Galante D; Russo M; Sardaro C; Gallo C; Gaeta GB
    Hepatogastroenterology; 1993 Aug; 40(4):365-9. PubMed ID: 8406307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.